Item 5. Other information

Rule 10b5-1 and Non-Rule 10b5-1 Trading Arrangements

During the three months ended March 31, 2024, certain of our officers and directors adopted or terminated trading arrangements for the sale of shares of our common stock as follows:


	Action		Date		Plans		Number of Securities to be Sold	Expiration
		Rule 10b5-1 1		Non-Rule 10b5-1 2
Tim Murphy, Chief Administrative Officer	Adoption		February 1, 2024		X	-	15,724 shares of Class A Common Stock	The earlier of (i) the date when all securities under plan are sold and (ii) December 31, 2024
Ling Hai, President, Asia Pacific, Europe, Middle East and Africa	Adoption		February 1, 2024		X	-	8,676 shares of Class A Common Stock underlying employee stock options	The earlier of (i) the date when all securities under plan are exercised and sold and (ii) February 28, 2025
Craig Vosburg, Chief Services Officer	Adoption		February 21, 2024		X	-	27,084 shares of Class A Common Stock underlying employee stock options	The earlier of (i) the date when all securities under plan are exercised and sold and (ii) November 22, 2024
Ajay Bhalla, Former President, Cyber and Intelligence Solutions 3	Adoption		February 23, 2024		X	-	42,248 shares of Class A Common Stock underlying employee stock options	The earlier of (i) the date when all securities under plan are exercised and sold and (ii) September 11, 2024
Raj Seshadri, Chief Commercial Payments Officer	Adoption		February 26, 2024		X	-	(i) 20,764 shares of Class A Common Stock underlying employee stock options and (ii) 3,199 shares of Class A Common Stock	The earlier of (i) the date when all securities under plan are exercised and sold and (ii) December 31, 2024

1Intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

2Not intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

3Mr. Bhalla departed Mastercard on April 5, 2024.

Other Information

Pursuant to Section 219 of the Iran Threat Reduction and Syria Human Rights Act of 2012, we hereby incorporate by reference herein the disclosure contained in Exhibit 99.1 of this Report.

Previous: Item 1A. Risk factors · Next: Item 6. Exhibits